Showing 1 - 10 of 279
Aktuell weisen die Krankenkassen und der Gesundheitsfonds Überschüsse von über 20 Mrd. Euro auf. Für Daniel Bahr, Bundesminister für Gesundheit, eröffnen diese Überschüsse – neben der Abschaffung der Praxisgebühr – Spielräume für Prämien. Die zentrale Herausforderung an eine...
Persistent link: https://www.econbiz.de/10010877382
Using SOEP panel data and difference-in-differences methods, this study is the first to empirically evaluate the effectiveness of four different health care cost containment measures within an integrated framework. The four measures investigated were introduced in Germany in 1997 to reduce moral...
Persistent link: https://www.econbiz.de/10011600994
A famous idea to maintain affordable health expenditures is to cut back statutory health insurance (SHI) to a basic insurance and to introduce supplementary private health insurance (PHI), permitted to cover the remaining benefits and to apply managed care mechanisms. The measure is supposed to...
Persistent link: https://www.econbiz.de/10010266017
Competition among health insurers is widely considered to be a means of enhancing efficiency and containing costs in the health care system. In this paper, it is argued that this could be unsuccessful since health care providers hold a strong position on the market for health care services....
Persistent link: https://www.econbiz.de/10010271400
Dieser Aufsatz bietet einen einführenden Überblick zur globalen Gesundheitsökonomie – unter besonderer Berücksichtigung der Allokation von Ressourcen, der Messung medizinischer Ergebnisse und der Bestimmungsgründe internationaler Variation. Daran anschließend werden gesundheitspolitische...
Persistent link: https://www.econbiz.de/10010273160
We study the impact of product margins on pharmacies' incentive to promote generics instead of brand-names. First, we construct a theoretical model where pharmacies can persuade patients with a brand-name prescription to purchase a generic version instead. We show that pharmacies' substitution...
Persistent link: https://www.econbiz.de/10010291561
Die demographische Entwicklung und der medizinisch-technische Fortschritt gelten als die beiden wichtigsten Gründe für den Anstieg der Gesundheitsausgaben. Der vorliegende Übersichtsartikel betrachtet den Einfluss der Alterung auf die Gesundheitsausgaben anhand der so genannten...
Persistent link: https://www.econbiz.de/10010300567
After years of stagnation and political cataclysms, Georgia tried to recover by launching radical economic and political reforms starting in 2004. The results of the reforms appeared to be impressive. The country's GDP has more than doubled; the total volume of bank deposits is five times what it...
Persistent link: https://www.econbiz.de/10010326598
This article examines the choice of health care in Japan by patients suffering from the common cold. Original data were obtained from a survey conducted by the authors. Empirical results show that the price elasticity of demand for medical services is between 0.23 and 0.36. This estimated price...
Persistent link: https://www.econbiz.de/10010332320
We study the impact of regulation on competition between brand-names and generics and pharmaceutical expenditures using a unique policy experiment in Norway, where reference pricing (RP) replaced price cap regulation in 2003 for a sub-sample of off-patent products. First, we construct a vertical...
Persistent link: https://www.econbiz.de/10010274913